Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study-Reference-Cited by-同舟云学术

Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study

Published:2022-03 Issue:10331 Volume:399 Page:1254-1264
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rearte Analía,Castelli Juan Manuel,Rearte Ramiro,Fuentes Nora,Pennini Velen,Pesce Martina,Barbeira Pilar Barcena,Iummato Luciana Eva,Laurora Melisa,Bartolomeu María Lucía,Galligani Guido,Del Valle Juarez María,Giovacchini Carlos María,Santoro Adrián,Esperatti Mariano,Tarragona Sonia,Vizzotti Carla

Funder

Ministerio de Salud de la Nación

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

2. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia;Logunov;Lancet,2021

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

4. COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room;Olliaro;Lancet Microbe,2021

5. Design of vaccine efficacy trials during public health emergencies;Dean;Sci Transl Med,2019

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of vaccine coverage and disruption to health services on COVID-19 in Ukraine;Scientific Reports;2024-06-26

2. Relative and Temporal Efficacy of the First and Second Covid 19 Booster Vaccine (3rd And 4th Dose) to Prevent Symptomatic Infection from December 2021 to October 2023 in a General Medicine Office in Toledo (Spain);Journal of Health Care and Research;2024-05-21

3. COVID-19 grave en el contexto de una población vacunada: Estudio de casos y controles;Revista de Epidemiologia e Controle de Infecção;2024-05-14

4. Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population;PLOS ONE;2024-04-05

5. Impact of the COVID-19 vaccination campaigns in Argentina during 2021: An observational quantification of the death probability for confirmed cases in Buenos Aires province;Heliyon;2024-03